Alignment Healthcare, Inc. — Form 8-K Summary
Business Context and Reporting Period
Filed January 9, 2023 under Item 7.01, Regulation FD. The filing provides an update on 2023 Annual Enrollment Period performance and reaffirms financial guidance for the fiscal year ended December 31, 2022. Management planned investor and analyst meetings from January 9–12, 2023.
Key Metrics and Guidance
| Metric | Fiscal 2022 Guidance |
|---|---|
| Revenue | $1.410 billion–$1.415 billion |
| Adjusted gross profit | $189 million–$192 million |
| Adjusted EBITDA | $(33) million–$(30) million |
The company estimated approximately 108,300 members in its HMO and PPO contracts as of January 1, 2023, representing approximately 17% year-over-year growth from January 1, 2022. This estimate excludes approximately 7,500 ACO REACH members.
The filing does not provide cash flow, GAAP profit or loss, margins, debt balances, liquidity balances, or fourth-quarter 2022 results. The company stated that it was still closing its fiscal 2022 books and would not provide additional fourth-quarter financial information at that time.
Material Changes Versus the Prior Comparable Period
- Estimated HMO and PPO membership increased approximately 17% year over year to approximately 108,300 members as of January 1, 2023.
- Fiscal 2022 revenue, adjusted gross profit, and adjusted EBITDA guidance was reaffirmed; the filing does not identify changes from the guidance issued November 3, 2022.
- The company will not provide forward-looking 2023 membership growth guidance until it issues its comprehensive 2023 guidance.
Outlook, Risks, and Unusual Items
- CMS was expected to release January 1, 2023 national enrollment data during January. The company identified a timing cutoff issue and expects the initial CMS file may underreport its membership until later reporting periods.
- Adjusted gross profit and adjusted EBITDA are non-GAAP measures. The company could not reconcile the guidance ranges to the corresponding GAAP measures without unreasonable effort because of uncertainty regarding items including equity-based compensation and depreciation and amortization.
- Key disclosed risks include member acquisition and new-market expansion, required governmental approvals, Medicare Five Star ratings, government-contractor requirements, regulatory changes, indebtedness and rising interest rates, market acceptance of technology and services, litigation or security incidents, labor shortages and costs, and COVID-19 impacts.
- The filing contains forward-looking statements that are subject to material risks and uncertainties. No duty to update the information was assumed except as required by law.
Important Facts for Investors to Verify
- Reconcile final January 1, 2023 membership with subsequent CMS enrollment data, including any correction for the reported timing issue.
- Confirm final fiscal 2022 revenue, GAAP results, adjusted gross profit, adjusted EBITDA, cash flow, debt, and liquidity when the company reports its completed results.
- Review the company’s comprehensive 2023 guidance, including membership growth and profitability expectations.
- Review the definitions and reconciliations for the non-GAAP measures when available.
- Assess the risk factors in the company’s Form 10-K for the year ended December 31, 2021 and subsequent SEC filings.